Skip to content
10-Q

Quarterly Report

NANOVIRICIDES, INC. NNVC

0001410578-24-001991

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Nov 14, 2024 14.35M sh
Cash And Equivalents Q1 2025 · Sep 30, 2024 $3.87M
Cash And Equivalents Q1 2025 · Jun 30, 2024 $4.8M
Current Liabilities Q1 2025 · Sep 30, 2024 $1.63M
Current Liabilities Q1 2025 · Jun 30, 2024 $1.36M
Total Liabilities Q1 2025 · Sep 30, 2024 $1.63M
Current Assets Q1 2025 · Sep 30, 2024 $4.04M
Current Assets Q1 2025 · Jun 30, 2024 $4.97M
Total Assets Q1 2025 · Sep 30, 2024 $11.74M
Total Assets Q1 2025 · Jun 30, 2024 $12.82M
Shares Diluted Q1 2025 · Sep 30, 2023 11.72M sh
Capex Q1 2025 · Sep 30, 2023 $8.29K
Operating Cash Flow Q1 2025 · Sep 30, 2023 −$1.17M
Stockholders Equity Q1 2025 · Sep 30, 2023 $12.97M
Stockholders Equity Q1 2025 · Jun 30, 2023 $14.87M
Eps Diluted Q1 2025 · Sep 30, 2023 −$0.17
Eps Basic Q1 2025 · Sep 30, 2023 −$0.17
Sga Expense Q1 2025 · Sep 30, 2023 $564.93K
Rd Expense Q1 2025 · Sep 30, 2023 $1.47M
Net Income Q1 2025 · Sep 30, 2023 −$1.97M
Operating Income Q1 2025 · Sep 30, 2023 −$2.03M